Browsing Department of Clinical Medicine by Subject "Overall survival"
Now showing items 1-3 of 3
Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) – study protocol for a national multicentre randomized controlled trial (BioMed Central, 2017-08-25)Background: Pancreatic cancer is the fourth leading cause of cancer-related death. While surgical resection remains the foundation for potentially curative treatment, survival benefit is achieved with adjuvant oncological ...Journal article
Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases (BioMed Central, 2015-12-03)Background: Despite progress in resection for colorectal liver metastases (CLM), the majority of patients experience recurrence. We aimed to evaluate factors influencing time to recurrence (TTR), treatment and post-recurrence ...Journal article
Surgery for colorectal liver metastases: the impact of resection margins on recurrence and overall survival (BioMed Central, 2014-04-27)Background: Several reports have presented conflicting results regarding the association between resection margins (RMs) and outcome after surgery for colorectal liver metastases (CLM), especially in the era of modern ...Journal article